CME Group Inc. (NASDAQ:CME) Announces Quarterly Dividend of $1.15

CME Group Inc. (NASDAQ:CME) announced a quarterly dividend on Thursday, November 7th, RTT News reports. Stockholders of record on Monday, December 9th will be given a dividend of 1.15 per share by the financial services provider on Friday, December 27th. This represents a $4.60 annualized dividend and a dividend yield of 2.08%.

CME Group has increased its dividend by an average of 9.0% annually over the last three years and has raised its dividend every year for the last 14 years. CME Group has a dividend payout ratio of 44.4% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect CME Group to earn $10.24 per share next year, which means the company should continue to be able to cover its $4.60 annual dividend with an expected future payout ratio of 44.9%.

CME Group Price Performance

Shares of CME Group stock traded down $0.47 on Thursday, hitting $220.70. 73,089 shares of the company traded hands, compared to its average volume of 1,910,308. The firm’s 50-day simple moving average is $221.36 and its 200 day simple moving average is $209.75. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. The company has a market cap of $79.47 billion, a P/E ratio of 23.26, a P/E/G ratio of 5.62 and a beta of 0.55. CME Group has a 12-month low of $190.70 and a 12-month high of $230.36.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, beating the consensus estimate of $2.65 by $0.03. The firm had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The business’s quarterly revenue was up 18.4% on a year-over-year basis. During the same quarter last year, the company posted $2.25 EPS. Analysts expect that CME Group will post 10.23 earnings per share for the current fiscal year.

Analyst Ratings Changes

CME has been the topic of a number of analyst reports. Deutsche Bank Aktiengesellschaft lifted their target price on shares of CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research report on Thursday, August 15th. Bank of America lifted their target price on shares of CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research report on Thursday, October 3rd. Morgan Stanley lifted their target price on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 17th. TD Cowen initiated coverage on shares of CME Group in a research report on Thursday, September 26th. They issued a “hold” rating and a $221.00 target price on the stock. Finally, JPMorgan Chase & Co. lifted their target price on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research report on Thursday, July 25th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, CME Group presently has a consensus rating of “Hold” and an average price target of $222.73.

Insider Buying and Selling at CME Group

In other news, insider Timothy Francis Mccourt sold 1,374 shares of CME Group stock in a transaction dated Monday, October 28th. The shares were sold at an average price of $227.12, for a total transaction of $312,062.88. Following the sale, the insider now owns 7,275 shares of the company’s stock, valued at approximately $1,652,298. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, insider Timothy Francis Mccourt sold 1,374 shares of CME Group stock in a transaction dated Monday, October 28th. The shares were sold at an average price of $227.12, for a total transaction of $312,062.88. Following the sale, the insider now owns 7,275 shares of the company’s stock, valued at approximately $1,652,298. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Timothy S. Bitsberger sold 1,000 shares of CME Group stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $226.96, for a total transaction of $226,960.00. Following the sale, the director now directly owns 10,589 shares in the company, valued at $2,403,279.44. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 15,621 shares of company stock worth $3,441,063. 0.30% of the stock is currently owned by company insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.